Table of Contents:

1 Report Prologue
2 Market Introduction
2.1 Specification of Dermal Fillers
2.1.1 Hyaluronic Acid
2.1.2 Botulinum Toxin
2.1.3 Collagen
2.1.4 Polymers and Particles
2.2 Scope of Study
2.2.1 Research Objective
2.2.2 Assumptions & Limitations
2.2.2.1 Assumptions
2.2.2.2 Limitations
2.3 Market structure
3 Research Methodology
3.1 Primary Research
3.2 Secondary research
3.3 Market Size Estimation
4 Market Dynamics
4.1 Drivers
4.1.1 Growing Demand for Facial Aesthetics Globally
4.1.2 Increasing Acceptance of Tissue Fillers And Growing Number Of Dermal Filler Surgeries
4.1.3 Rising Awareness About Combination Therapies
4.1.4 Growing Ageing population
4.2 Restrains
4.2.1 Side Effects Associated With Dermal Fillers
4.2.2 Dermal Fillers Black Market and Effects of Unregistered Practitioners
5 Market Factor Analysis
5.1 Porters five Forces
5.1.1 Bargaining power of suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 Introduction
5.2.1.1 Inputs
5.2.1.2 Drug Development
5.2.1.3 Manufacturing process of facial injectable
5.2.1.4 Marketing and distribution
6 Global Dermal Fillers Market By Types
6.1 Botulinum Toxin
6.2 Hyaluronic Acid
6.3 Polymers & Particles
6.4 Collagen
7 Global Dermal Fillers Market By Application
7.1 Facial Line Correction Treatment
7.2 Face-Lift
7.3 Lip Treatments
8 Global Dermal Fillers Market by Regions
8.1 Americas
8.1.1 North America
8.1.1.1 US
8.1.1.2 Canada
8.1.2 Latin America
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 UK
8.2.4 Italy
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 China
8.3.2 Japan
8.3.3 India
8.3.4 South Korea
8.3.5 Rest of Asia Pacific
8.4 Middle East & Africa
9 Competitive Landscape
9.1 Mergers Acquisitions
9.2 Approvals and Product Launches
9.3 Others
10 Company Profiles
10.1 GALDERMA
10.1.1 Company Overview
10.1.2 Product Overview
10.1.3 Financial Overview
10.1.4 Key Developments
10.2 ALLERGAN
10.2.1 Company Overview
10.2.2 Product Overview
10.2.3 Financial Overview
10.2.4 Key Development
10.3 Merz Pharma
10.3.1 Company Overview
10.3.2 Product Overview
10.3.3 Financial Overview
10.3.4 Key developments
10.4 Dr. Korman Laboratories
10.4.1 Company Overview
10.4.2 Product Overview
10.4.3 Financial Overview
10.5 Sinclair Pharma
10.5.1 Company Overview
10.5.2 Product Overview
Financial Overview 79
10.5.3 Key Development
10.6 Teoxane laboratories
10.6.1 Company Overview
10.6.2 Product Overview
10.6.3 Financial Overview
10.7 Integra Lifesciences
10.7.1 Company Overview
10.7.2 Product Overview
10.7.3 Financial Overview
10.7.4 Key Developments
11 Conclusion
11.1 Key Companies to watch
12 Appendix